BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29621314)

  • 1. Sildenafil ameliorates right ventricular early molecular derangement during left ventricular pressure overload.
    Imai Y; Kariya T; Iwakiri M; Yamada Y; Takimoto E
    PLoS One; 2018; 13(4):e0195528. PubMed ID: 29621314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right ventricular cyclic nucleotide signaling is decreased in hyperoxia-induced pulmonary hypertension in neonatal mice.
    Heilman RP; Lagoski MB; Lee KJ; Taylor JM; Kim GA; Berkelhamer SK; Steinhorn RH; Farrow KN
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1575-82. PubMed ID: 25862831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding.
    Rai N; Veeroju S; Schymura Y; Janssen W; Wietelmann A; Kojonazarov B; Weissmann N; Stasch JP; Ghofrani HA; Seeger W; Schermuly RT; Novoyatleva T
    Biomed Res Int; 2018; 2018():3293584. PubMed ID: 29511676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload.
    Borgdorff MA; Bartelds B; Dickinson MG; van Wiechen MP; Steendijk P; de Vroomen M; Berger RM
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H361-9. PubMed ID: 24878769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil ameliorates left ventricular T-tubule remodeling in a pressure overload-induced murine heart failure model.
    Huang CK; Chen BY; Guo A; Chen R; Zhu YQ; Kutschke W; Hong J; Song LS
    Acta Pharmacol Sin; 2016 Apr; 37(4):473-82. PubMed ID: 26972492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice.
    Pradhan K; Sydykov A; Tian X; Mamazhakypov A; Neupane B; Luitel H; Weissmann N; Seeger W; Grimminger F; Kretschmer A; Stasch JP; Ghofrani HA; Schermuly RT
    Int J Cardiol; 2016 Aug; 216():85-91. PubMed ID: 27140341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cGMP in the physiological and molecular responses of the right ventricle to pressure overload.
    Janssen W; Schermuly RT; Kojonazarov B
    Exp Physiol; 2013 Aug; 98(8):1274-8. PubMed ID: 23873899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crucial role of rho-kinase in pressure overload-induced right ventricular hypertrophy and dysfunction in mice.
    Ikeda S; Satoh K; Kikuchi N; Miyata S; Suzuki K; Omura J; Shimizu T; Kobayashi K; Kobayashi K; Fukumoto Y; Sakata Y; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1260-71. PubMed ID: 24675663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The left ventricle undergoes biomechanical and gene expression changes in response to increased right ventricular pressure overload.
    Kheyfets VO; Dufva MJ; Boehm M; Tian X; Qin X; Tabakh JE; Truong U; Ivy D; Spiekerkoetter E
    Physiol Rep; 2020 May; 8(9):e14347. PubMed ID: 32367677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early versus late cardiac remodeling during right ventricular pressure load and impact of preventive versus rescue therapy with endothelin-1 receptor blockers.
    Ramos SR; Pieles G; Sun M; Slorach C; Hui W; Friedberg MK
    J Appl Physiol (1985); 2018 May; 124(5):1349-1362. PubMed ID: 29446710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.
    Potoka KP; Wood KC; Baust JJ; Bueno M; Hahn SA; Vanderpool RR; Bachman T; Mallampalli GM; Osei-Hwedieh DO; Schrott V; Sun B; Bullock GC; Becker-Pelster EM; Wittwer M; Stampfuss J; Mathar I; Stasch JP; Truebel H; Sandner P; Mora AL; Straub AC; Gladwin MT
    Am J Respir Cell Mol Biol; 2018 May; 58(5):636-647. PubMed ID: 29268036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
    Takimoto E; Champion HC; Li M; Belardi D; Ren S; Rodriguez ER; Bedja D; Gabrielson KL; Wang Y; Kass DA
    Nat Med; 2005 Feb; 11(2):214-22. PubMed ID: 15665834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular hypertrophy causes impairment of left ventricular diastolic function in the rat.
    Lamberts RR; Vaessen RJ; Westerhof N; Stienen GJ
    Basic Res Cardiol; 2007 Jan; 102(1):19-27. PubMed ID: 16944361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.
    Westermann D; Becher PM; Lindner D; Savvatis K; Xia Y; Fröhlich M; Hoffmann S; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2012 Nov; 107(6):308. PubMed ID: 23117837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of phosphodiesterase-5 inhibition by sildenafil in the pressure overloaded right heart.
    Andersen A; Nielsen JM; Peters CD; Schou UK; Sloth E; Nielsen-Kudsk JE
    Eur J Heart Fail; 2008 Dec; 10(12):1158-65. PubMed ID: 19004667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine.
    Hiemstra JA; Lee DI; Chakir K; Gutiérrez-Aguilar M; Marshall KD; Zgoda PJ; Cruz Rivera N; Dozier DG; Ferguson BS; Heublein DM; Burnett JC; Scherf C; Ivey JR; Minervini G; McDonald KS; Baines CP; Krenz M; Domeier TL; Emter CA
    J Am Heart Assoc; 2016 Apr; 5(4):e003277. PubMed ID: 27098966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway.
    Hsu S; Nagayama T; Koitabashi N; Zhang M; Zhou L; Bedja D; Gabrielson KL; Molkentin JD; Kass DA; Takimoto E
    Cardiovasc Res; 2009 Feb; 81(2):301-9. PubMed ID: 19029137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
    AbouEzzeddine OF; McKie PM; Dunlay SM; Stevens SR; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
    Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
    Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right ventricular failure resulting from pressure overload: role of intra-aortic balloon counterpulsation and vasopressor therapy.
    Liakopoulos OJ; Ho JK; Yezbick AB; Sanchez E; Singh V; Mahajan A
    J Surg Res; 2010 Nov; 164(1):58-66. PubMed ID: 19766243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.